Articles Related to Transplantation
A Single-Center Experience in Alport Syndrome
Alport Syndrome is a hereditary condition that affects the collagen in the basement membrane and is characterized by microscopic hematuria, sensorineural hearing loss, increasing renal dysfunction, and ocular abnormalities. It is
more common between the ages of 20 and 30. Men and women are equally affected. However, the prognosis of men is
worse than women due to renal failure. The purpose of this study is to evaluate the demographic and clinical findings of patients with Alport Syndrome in our center
Novel Antibiotics for Bloodstream Infections in HSCT
Bloodstream infections (BSI) are one of severe infectious complications faced by hematopoietic stem cell transplantation (HSCT) patients. BSI increases significantly the morbidity and mortality of HSCT patients. Gram-positive bacteria occurred more frequency than gram-negative bacteria over past decades, but rates of gram-negative bloodstream infections have recently increased again. Antibacterial prophylaxis could be justified in HSCT, infections caused by resistant pathogens increased mortality. New antibiotics such as omadacycline, meropenem/vaborbactam, eravacycline, ceftobiprole, tedizolid, dalbavancin, cefiderocol hold promise for the treatment of highly resistant pathogens.
Evaluation of Infectious and Malignant Complications in Elderly Renal Transplant Recipients Receiving Alemtuzumab Compared to Basiliximab
The choice of induction immunosuppression can affect several outcomes after kidney transplant (KTx). We aimed to evaluate infectious and malignant complications between alemtuzumab and basiliximab in elderly KTx recipients. Patients ≥ 65 years old who received alemtuzumab or basiliximab induction for their primary KTx from 2006 – 2018 were included.
Comparison of Hemodialysis Patients and Healthy Individuals Attitudes towards Organ Donation: A Descriptive Study
The research is comparative descriptive type. The sample of the study consisted of a total of 167 people, including 82 hemodialysis patients and 85 healthy individuals who applied to the Family Health Center. The data of the study were obtained using the questionnaire and organ donation attitude scale. SPSS 25 was used in the analysis of the data.
Adynamic Donor Ureter: A Case Report with Review of the Literature
We report a unique case of a male recipient who received a zero mismatch kidney with mild anatomical anomalies from his sister. This right kidney was malrotated, had an extra renal pelvis with moderately dilated ureter up to the iliac artery bifurcation. Immediate graft function was achieved on reperfusion, and the recipient was discharged on day 7 with a serum creatinine (SC) of 1.8mg/dl. The DJ stent was removed after 6 weeks, with a rapid increase in SC to 3.5mg/dl, and ultrasound showed mild hydronephrosis with delayed
excretion on nuclear imaging. Mechanical obstruction was excluded by retrograde pyelography, and a 5F DJ stent was placed across the ureterovesical anastomosis with an immediate decrease in SC. The case is presented in detail and discussed in the light of the current literature.
Introduction of Stem Cells in Ophthalmology
Stem cells are relatively undifferentiated, with unlimited proliferative ability; self-renewal capability and also they can
differentiate into specialized cells. Somatic stem cells in adult organisms are responsible for regenerating and self-renewing tissue.
Many different stem cell types reside in the eye.
Treosulfan Plus Fludarabine – Encouraging Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Multiple Myeloma
Allogeneic transplantation (Allo-SCT) in multiple myeloma is controversial mainly due to the relatively high non-relapse mortality (NRM). The aim with this retrospective single-center study was to evaluate recent transplants particularly after conditioning with treosulfan plus fludarabine (TreoFlu).
Responses and Survival under Pegylated Interferon α2a Treatment for Patients with Post-MPN Acute Myeloid Leukemia and Acute Panmyelosis with Myelofibrosis
We report here for the first time the efficacy of pegylated interferon α2a (Peg-Ifn) as a therapy for patients with myelofibrosis and high blast counts. We treated four patients who were in an accelerated phase of myeloproliferative neoplasms or acute panmyelosis with myelofibrosis using only this drug.
Candidate Selection, Determinant Factor for a Good Result in Cardiac Retransplantation: our Experience
Cardiac retransplantation is the standard treatment for patients with advanced graft vasculopathy. It remains controversial due to the scarcity of donors and poor results when compared with the novo transplant.
Influence of Maternal Nutritional Factors on Ovarian Folliculogenesis in Cattle
Assisted reproductive technologies, such as artificial insemination and embryo transfer, have produced significant outcomes in cattle. These technologies are useful not only for improving fertility but also for increasing the rate of genetic change in beef and dairy livestock. Today, embryo transfer in cattle is both practical and commercially viable. However, bovine embryo transplantation still remains suboptimal under on-farm conditions, one of the main reasons for which may be inefficient nutritional management.
A Descriptive Study about Dilated Cardiomyopathy in Children in a Tertiary Hospital in Nigeria
Dilated Cardiomyopathy is the most common form of the cardiomyopathies in children accounting for a significant cause of morbidity and mortality as well as a common indication for heart transplant.
Pharmacy Compounding Quality Control and Pharmaceutical Development Strategies for Seventeen alpha Hydroxyprogesterone Caproate in Prevention of Preterm Delivery
Seventeen alpha hydroxyprogesterone caproate (17-OHPC) is the only FDA-approved drug labeled for prevention of preterm delivery. This drug is also available as a compounded product from licensed compounding pharmacies. This article reviews the FDA approval history and pharmacy compounding quality control data of 17-OHPC, as well as briefly discusses possible future pharmaceutical development strategies for 17-OHPC.
Editorial Board Members Related to Transplantation
Peter Schemmer
Professor
Department of General -, Visceral- and Transplant Surgery
University Hospital of Heidelberg
Germany
Department of General -, Visceral- and Transplant Surgery
University Hospital of Heidelberg
Germany
Eva Mischak-Weissinger
Professor
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation
Hannover Medical School
Germany
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation
Hannover Medical School
Germany
Annapaola Zito
Professor
Cardiovascular Diseases Section
University of Bari
Italy
Cardiovascular Diseases Section
University of Bari
Italy
J. Philip Boudreaux
Professor
Department of Surgery
Louisiana State University Health Sciences Center
United States
Department of Surgery
Louisiana State University Health Sciences Center
United States
Jae Hwa Kim
Professor
Department of Orthopedics
CHA Bundang Medical Center
CHA University
Korea
Department of Orthopedics
CHA Bundang Medical Center
CHA University
Korea
David Ilki Min
Professor
Pharmacy Practice and Administration
Western University of Health Sciences
United States
Pharmacy Practice and Administration
Western University of Health Sciences
United States
RICHARD K. GILROY
Professor of Medicine
Medical Director of Liver Transplantation
Department of Gastroenterology and Hepatology
University of Kansas Medical Center
United States
Medical Director of Liver Transplantation
Department of Gastroenterology and Hepatology
University of Kansas Medical Center
United States
M Reza Movahed
Professor
Department of Medicine
University of Arizona
USA
Department of Medicine
University of Arizona
USA
Dagmara McGuinness
Research Associate
College of Medical
Veterinary & Life Sciences
Institute of Cancer Sciences
Western Infirmary Glasgow
Scotland
College of Medical
Veterinary & Life Sciences
Institute of Cancer Sciences
Western Infirmary Glasgow
Scotland
STEFAN KOSTADINOV
Assistant Professor
Alpert Medical School
Brown University
United States
Alpert Medical School
Brown University
United States